Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity.

Movement disorders : official journal of the Movement Disorder Society - 1 Jun 2023

Borsche Max, Pratuseviciute Neringa, Schaake Susen, Hinrichs Frauke, Morel Gabriel, Uter Jan, Lohmann Katja, Klein Christine, Alessi Dario R, Hagenah Johann, Sammler Esther

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Share to Lysosomal Storage Disorders Research
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neurological diseases and metabolism

Share to Parkinson Disease

Share to Parkinson's Disease Mechanisms and Treatments

Share to Phosphorylation

Source

Open in PubMed Open full text

Identifiers

PMID: 36971062
DOI: 10.1002/mds.29385
PMCID: PMC10947214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The New p.F1700L LRRK2 Variant Causes Parkinson's Disease by Extensively Increasing Kinase Activity.PMID 36971062Read ↗

Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variantSemantic proximity Read ↗

Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variantSemantic proximity Read ↗

MDSGene update and expansion: Clinical and genetic spectrum of<i>LRRK2</i>variants in Parkinson’s diseaseSemantic proximity Read ↗

The LRRK2 p.L1795F variant causes Parkinson’s disease in the European populationSemantic proximity Read ↗

Parkinson's Disease: The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease geneticsSemantic proximity Read ↗

Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased riskSemantic proximity Read ↗

Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.Semantic proximity Read ↗

Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.Semantic proximity Read ↗

Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's diseaseSemantic proximity Read ↗

The Discovery of LRRK2 Mutations as a Cause of Parkinson's Disease.Semantic proximity Read ↗

A common LRRK2 mutation in idiopathic Parkinson's diseaseSemantic proximity Read ↗

Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.